![A Multimodal Hair-Loss Treatment Strategy Using a New Topical Phytoactive Formulation: A Report of Five Cases A Multimodal Hair-Loss Treatment Strategy Using a New Topical Phytoactive Formulation: A Report of Five Cases](https://static.hindawi.com/articles/cridm/volume-2021/6659943/figures/6659943.fig.009a.jpg)
A Multimodal Hair-Loss Treatment Strategy Using a New Topical Phytoactive Formulation: A Report of Five Cases
![Drug-induced diffuse hair loss in females: An observational study Garg T, Yadav P, Agarwal S, Mendiratta V - Astrocyte Drug-induced diffuse hair loss in females: An observational study Garg T, Yadav P, Agarwal S, Mendiratta V - Astrocyte](http://www.astrocyte.in/articles/2014/1/2/images/Astrocyte_2014_1_2_80_137849_t2.jpg)
Drug-induced diffuse hair loss in females: An observational study Garg T, Yadav P, Agarwal S, Mendiratta V - Astrocyte
![Topical Diclofenac 3% Gel for Actinic Keratosis May Induce Terminal Hair in Male Androgenetic Alopecia: A Report of Three Cases | Journal of Skin and Stem Cell | Full Text Topical Diclofenac 3% Gel for Actinic Keratosis May Induce Terminal Hair in Male Androgenetic Alopecia: A Report of Three Cases | Journal of Skin and Stem Cell | Full Text](http://services.brieflands.com/cdn/serve/313e9/a7ecfaa46ad0a335e84299b3a68b0148e09f934c/jssc-2-4-33470-g001-preview.png)
Topical Diclofenac 3% Gel for Actinic Keratosis May Induce Terminal Hair in Male Androgenetic Alopecia: A Report of Three Cases | Journal of Skin and Stem Cell | Full Text
![Hazardous impact of diclofenac on mammalian system: Mitigation strategy through green remediation approach - ScienceDirect Hazardous impact of diclofenac on mammalian system: Mitigation strategy through green remediation approach - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0304389421010992-ga1.jpg)
Hazardous impact of diclofenac on mammalian system: Mitigation strategy through green remediation approach - ScienceDirect
![Topical Diclofenac 3% Gel for Actinic Keratosis May Induce Terminal Hair in Male Androgenetic Alopecia: A Report of Three Cases | Journal of Skin and Stem Cell | Full Text Topical Diclofenac 3% Gel for Actinic Keratosis May Induce Terminal Hair in Male Androgenetic Alopecia: A Report of Three Cases | Journal of Skin and Stem Cell | Full Text](http://services.brieflands.com/cdn/serve/313e9/1f9c91dab4c0ff7c07bbcbbae4e5216795d82e95/jssc-2-4-33470-g002-preview.png)
Topical Diclofenac 3% Gel for Actinic Keratosis May Induce Terminal Hair in Male Androgenetic Alopecia: A Report of Three Cases | Journal of Skin and Stem Cell | Full Text
![Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases](https://pub.mdpi-res.com/cancers/cancers-14-04385/article_deploy/html/images/cancers-14-04385-g002.png?1662701543)
Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases
![Topical cetirizine for the management of androgenic alopecia: Results of a pilot study - Seifian - Journal of Cosmetic Dermatology - Wiley Online Library Topical cetirizine for the management of androgenic alopecia: Results of a pilot study - Seifian - Journal of Cosmetic Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/904cbbaf-c05d-4b1a-9ded-67efcf22c657/jocd15989-fig-0001-m.jpg)
Topical cetirizine for the management of androgenic alopecia: Results of a pilot study - Seifian - Journal of Cosmetic Dermatology - Wiley Online Library
![Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases](https://pub.mdpi-res.com/cancers/cancers-14-04385/article_deploy/html/images/cancers-14-04385-g001.png?1662701546)
Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases
![PDF) Topical Diclofenac 3% Gel for Actinic Keratosis May Induce Terminal Hair in Male Androgenetic Alopecia: A Report of Three Cases PDF) Topical Diclofenac 3% Gel for Actinic Keratosis May Induce Terminal Hair in Male Androgenetic Alopecia: A Report of Three Cases](https://www.researchgate.net/profile/Helena-Collgros-2/publication/302483501/figure/fig2/AS:361156494544901@1463117826372/Case-2_Q320.jpg)